Table 2.
Sample | No. of positive samples/no. tested | |||
---|---|---|---|---|
DENV1 RT-PCR | DENV2 RT-PCR | DENV3 RT-PCR | DENV4 RT-PCR | |
DENV1 isolates | 11/11 | 0/11 | 0/11 | 0/11 |
DENV2 isolates | 0/5 | 5/5 | 0/5 | 0/5 |
DENV3 isolates | 0/6 | 0/6 | 6/6 | 0/6 |
DENV4 isolates | 0/2 | 0/2 | 0/2 | 2/2 |
QCMD panel, DENV1 | 17/17 | 0/17 | 0/17 | 0/17 |
QCMD panel, DENV2 | 0/11 | 11/11 | 0/11 | 0/11 |
QCMD panel, DENV3 | 0/8 | 0/8 | 8/8 | 0/8 |
QCMD panel, DENV4 | 0/4 | 0/4 | 0/4 | 4/4 |
QCMD negative controls | 0/8 | 0/8 | 0/8 | 0/8 |
RNA preparations from DENV1, DENV2, DENV3, and DENV4 isolates obtained Cq-values between 16 and 25 when analyzed using their respective serotype-specific RT-PCR assay
The concentrations of DENV1, DENV2, and DENV3 included in the QCMD panels were 103 to 106, 102 to 105, and 103 to 105 copies/mL, respectively. The concentration of DENV4 was 105 copies/mL in all four QCMD panel samples